Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 16 (RN7SKP16) is a processed pseudogene related to the functional *RN7SK* gene, which encodes 7SK small nuclear RNA. While the *RN7SK* gene is important for the regulation of transcription elongation via control of positive transcription elongation factor b (P-TEFb)[1][2][3], RN7SKP16 is a pseudogene and is not known to produce a functional RNA or have any biological function. Pseudogenes are generally non-functional copies or fragments of genes that have lost their original gene function through mutation or lack of regulatory elements. There are no known disease associations, interacting drugs, mechanisms of action, or roles as a biomarker for RN7SKP16. RN7SKP16 should not be considered a molecular target for therapeutics, research, or clinical biomarker strategies[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 16 (RN7SKP16).